pillbase.ru

Lenvima

Active substance: lenvatinib

CAPSULE · LENVATINIB 10 mg/1

United StatesActive

Marketing holder: Eisai Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Kisplyx
    lenvatinib mesilate
    EMEA/H/C/004224
    Eisai GmbH
  • Lenvima
    lenvatinib mesilate
    EMEA/H/C/003727
    Eisai GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-8b71-72db-bee4-0f31fe4dde31,01a12092-2433-76a8-b5b7-e4465e775ab3,01a12094-0a6f-7a75-bb49-f8516af7c796,01a12094-0a75-7ecd-8e55-885c8d0bb893,01a12098-f921-70a2-b951-4b83f36a174c;count=8 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
62856-720
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 62856-720 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 62856-720 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 62856-720 · Verified 2026-10-09 · open in source